MiroBio’s $97 Million Series B Financing

Wilson Sonsini Goodrich & Rosati and Goodwin advised MiroBio on the deal.MiroBio, a leader in the development of checkpoint agonists to treat autoimmune diseases, announced the…

This content is for Standard 1 Year members only.
Login Join Now
Martina Bellini

Author: Martina Bellini

This content is for Standard 1 Year members only.
Login Join Now